Pharmacogenetic analysis of lithium-induced delayed aging in Caenorhabditis elegans

被引:155
作者
McColl, Gawain [1 ]
Killilea, David W. [2 ]
Hubbard, Alan E. [3 ]
Vantipalli, Maithili C. [1 ]
Melov, Simon [1 ]
Lithgow, Gordon J. [1 ]
机构
[1] Buck Inst Age Res, Novato, CA 94945 USA
[2] Childrens Hosp Oakland, Res Inst, Ctr Nutr & Metabol, Oakland, CA 94609 USA
[3] Univ Calif Berkeley, Sch Publ Hlth, Berkeley, CA 94720 USA
关键词
D O I
10.1074/jbc.M705028200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Lithium (Li+) has been used to treat mood affect disorders, including bipolar, for decades. This drug is neuroprotective and has several identified molecular targets. However, it has a narrow therapeutic range and the one or more underlying mechanisms of its therapeutic action are not understood. Here we describe a pharmacogenetic study of Li+ in the nematode Caenorhabditis elegans. Exposure to Li+ at clinically relevant concentrations throughout adulthood increases survival during normal aging (up to 46% median increase). Longevity is extended via a novel mechanism with altered expression of genes encoding nucleosome-associated functions. Li+ treatment results in reduced expression of the worm ortholog of LSD-1 (T08D10.2), a histone demethylase; knockdown by RNA interference of T08D10.2 is sufficient to extend longevity (similar to 25% median increase), suggesting Li+ regulates survival by modulating histone methylation and chromatin structure.
引用
收藏
页码:350 / 357
页数:8
相关论文
共 61 条
[1]   Regulation of the Caenorhabditis elegans oxidative stress defense protein SKN-1 by glycogen synthase kinase-3 [J].
An, JH ;
Vranas, K ;
Lucke, M ;
Inoue, H ;
Hisamoto, N ;
Matsumoto, K ;
Blackwell, TK .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2005, 102 (45) :16275-16280
[2]  
BEANAN MJ, 1992, DEVELOPMENT, V116, P755
[3]   CONTROLLING THE FALSE DISCOVERY RATE - A PRACTICAL AND POWERFUL APPROACH TO MULTIPLE TESTING [J].
BENJAMINI, Y ;
HOCHBERG, Y .
JOURNAL OF THE ROYAL STATISTICAL SOCIETY SERIES B-STATISTICAL METHODOLOGY, 1995, 57 (01) :289-300
[4]   C. elegans SIR-2.1 interacts with 14-3-3 proteins to activate DAF-16 and extend life span [J].
Berdichevsky, Ala ;
Viswanathan, Mohan ;
Horvitz, H. Robert ;
Guarente, Leonard .
CELL, 2006, 125 (06) :1165-1177
[5]   Lithium rescues toxicity of aggregate-prone proteins in Drosophila by perturbing Wnt pathway [J].
Berger, Z ;
Ttofi, EK ;
Michel, CH ;
Pasco, MY ;
Tenant, S ;
Rubinsztein, DC ;
O'Kane, CJ .
HUMAN MOLECULAR GENETICS, 2005, 14 (20) :3003-3011
[6]   Calorie restriction, SIRT1 and metabolism: Understanding longevity [J].
Bordone, L ;
Guarente, L .
NATURE REVIEWS MOLECULAR CELL BIOLOGY, 2005, 6 (04) :298-305
[7]   LITHIUM SALTS IN THE TREATMENT OF PSYCHOTIC EXCITEMENT [J].
CADE, JFJ .
MEDICAL JOURNAL OF AUSTRALIA, 1949, 2 (10) :349-352
[8]   Glycogen synthase kinase-3β inhibitors prevent cellular polyglutamine toxicity caused by the Huntington's disease mutation [J].
Carmichael, J ;
Sugars, KL ;
Bao, YP ;
Rubinsztein, DC .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (37) :33791-33798
[9]   The mood-stabilizing agents lithium and valproate robustly increase the levels of the neuroprotective protein bcl-2 in the CNS [J].
Chen, G ;
Zeng, WZ ;
Yuan, PX ;
Huang, LD ;
Jiang, YM ;
Zhao, ZH ;
Manji, HK .
JOURNAL OF NEUROCHEMISTRY, 1999, 72 (02) :879-882
[10]   Long term lithium treatment suppresses p53 and Bax expression but increases Bcl-2 expression - A prominent role in neuroprotection against excitotoxicity [J].
Chen, RW ;
Chuang, DM .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (10) :6039-6042